Xilio Therapeutics, Inc. - XLO

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 16
Latest filed: Nov 16, 2026
Form Count
4 8
SCHEDULE 13G 3
8-K 3
SCHEDULE 13G/A 2

Latest files

Filed Form Report period Accession SEC
Nov 16, 2026 SCHEDULE 13G — 0000935836-26-000612 View
Nov 16, 2026 SCHEDULE 13G — 0001104659-26-128741 View
Nov 13, 2026 SCHEDULE 13G/A — 0001104659-26-127419 View
Nov 12, 2026 SCHEDULE 13G — 0000919574-26-007551 View
Nov 10, 2026 8-K Nov 10, 2026 0001193125-26-454449 View
Oct 02, 2026 4 Oct 01, 2026 0001193125-26-412466 View
Aug 14, 2026 SCHEDULE 13G/A — 0001104659-26-096755 View
Aug 12, 2026 8-K Aug 12, 2026 0001193125-26-345753 View
Jun 12, 2026 8-K Jun 10, 2026 0001193125-26-269358 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269395 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269396 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269397 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269398 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269401 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269399 View
Jun 12, 2026 4 Jun 11, 2026 0001193125-26-269400 View